Möchten Sie über diese Zeitschrift informiert bleiben? Klicken Sie bitte auf die Buttons, um unsere Alerts zu abonnieren.
Möchten Sie über diese Zeitschrift informiert bleiben? Klicken Sie bitte auf die Buttons, um unsere Alerts zu abonnieren.
We recently presented the strain Bacteroides xylanisolvens DSM 23964 to be safe for use in food. In order to confirm the tolerance of healthy humans to a regular oral intake of the strain B. xylanisolvens DSM 23964, we here report on the safety data of two successive human studies: a randomised and double-blind parallel group-controlled pilot study with 41 volunteers receiving a daily dose of a pasteurised fermented milk product containing up to 8.5×1011B. xylanisolvens DSM 23964 cells for 3 weeks, and a randomised and placebo-controlled double-blind major study with 140 volunteers receiving the same product but spray-dried and containing up to 1012 cells for 6 weeks. In both studies no persistent side effects of any kind were reported. The measured haematological parameters, and the serum concentrations of immunoglobulin and of inflammatory markers (IL-6, CRP, IFN-γ) were unaffected by the supplementation in both studies. A small decrease in the phagocytic activity of granulocytes and a small increase of TNF-α detected in the pilot study were both invalidated by the major study. This study further revealed that the supplementation induced no modification in natural killer cell activity and in liver enzyme values (gamma-glutamyl-transferase, glutamate-oxalacetate transaminase, glutamate-pyruvate transaminase). Our results definitively demonstrate that the pasteurised B. xylanisolvens DSM 23964 strain is safe and well tolerated by healthy human individuals.
Adams, C.A., 2010. The probiotic paradox: live and dead cells are biological response modifiers. Nutrition Research Reviews 23: 37-46.
'The probiotic paradox: live and dead cells are biological response modifiers ' () 23 Nutrition Research Reviews : 37 -46.
Comstock, L.E., 2009. Importance of glycans to the host-Bacteroides mutualism in the mammalian intestine. Cell Host and Microbe 5: 522-526.
'Importance of glycans to the host-Bacteroides mutualism in the mammalian intestine ' () 5 Cell Host and Microbe : 522 -526.
Dasgupta, S. and Kasper, D.L., 2010. Novel tools for modulating immune responses in the host-polysaccharides from the capsule of commensal bacteria. Advances in Immunology 106: 61-91.
'Novel tools for modulating immune responses in the host-polysaccharides from the capsule of commensal bacteria ' () 106 Advances in Immunology : 61 -91.
Erickson, K.L. and Hubbard, N.E., 2000. Probiotic immunomodulation in health and disease. The Journal of Nutrition 130: 403-409.
'Probiotic immunomodulation in health and disease ' () 130 The Journal of Nutrition : 403 -409.
Food and Agricultural Organization of the United Nations/World Health Organization (FAO/WHO), 2001. Health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria. Available at: http://www.who.int/entity/ foodsafety/publications/fs_management/en/probiotics.pdf.
Fuller, R., 1989. Probiotics in man and animals. Journal of Applied Bacteriology 66: 365-378.
'Probiotics in man and animals ' () 66 Journal of Applied Bacteriology : 365 -378.
Galdeano, C.M., De Moreno, L.A., Vinderola, G., Bonet, M.E. and Perdigon, G., 2007. Proposed model: mechanisms of immunomodulation induced by probiotic bacteria. Clinical and Vaccine Immunology 14: 485-492.
'Proposed model: mechanisms of immunomodulation induced by probiotic bacteria ' () 14 Clinical and Vaccine Immunology : 485 -492.
Gardiner, G.E., O’Sullivan, E., Kelly, J., Auty, M.A., Fitzgerald, G.F., Collins, J.K., Ross, R.P. and Stanton, C., 2000. Comparative survival rates of human-derived probiotic Lactobacillus paracasei and L. salivarius strains during heat treatment and spray drying. Applied and Environmental Microbiology 66: 2605-2612.
'Comparative survival rates of human-derived probiotic Lactobacillus paracasei and L. salivarius strains during heat treatment and spray drying ' () 66 Applied and Environmental Microbiology : 2605 -2612.
Gerard, P., Lepercq, P., Leclerc, M., Gavini, F., Raibaud, P. and Juste, C., 2007. Bacteroides sp. strain D8, the first cholesterol-reducing bacterium isolated from human feces. Applied and Environmental Microbiology 73: 5742-5749.
'Bacteroides sp. strain D8, the first cholesterol-reducing bacterium isolated from human feces ' () 73 Applied and Environmental Microbiology : 5742 -5749.
Gill, H.S., 1998. Stimulation of the immune system by lactic cultures. International Dairy Journal 8: 535-544.
'Stimulation of the immune system by lactic cultures ' () 8 International Dairy Journal : 535 -544.
Guarner, F., Perdigon, G., Corthier, G., Salminen, S., Koletzko, B. and Morelli, L., 2005. Should yoghurt cultures be considered probiotic? British Journal of Nutrition 93: 783-786.
'Should yoghurt cultures be considered probiotic? ' () 93 British Journal of Nutrition : 783 -786.
Hosseini, E., Grootaert, C., Verstraete, W. and Van de Wiele, T., 2011. Propionate as a health-promoting microbial metabolite in the human gut. Nutrition Reviews 69: 245-258.
'Propionate as a health-promoting microbial metabolite in the human gut ' () 69 Nutrition Reviews : 245 -258.
Izumo, T., Ida, M., Maekawa, T., Furukawa, Y., Kitagawa, Y. and Kiso, Y., 2011. Comparison of the immunomodulatory effects of live and heat-killed Lactobacillus pentosus S-PT84. Journal of Health Science 57: 304-310.
'Comparison of the immunomodulatory effects of live and heat-killed Lactobacillus pentosus S-PT84 ' () 57 Journal of Health Science : 304 -310.
Kataria, J., Li, N., Wynn, J.L. and Neu, J., 2009. Probiotic microbes: do they need to be alive to be beneficial? Nutrition Reviews 67: 546-550.
'Probiotic microbes: do they need to be alive to be beneficial? ' () 67 Nutrition Reviews : 546 -550.
Kelly, D., Conway, S. and Aminov, R., 2005. Commensal gut bacteria: mechanisms of immune modulation. Trends in Immunology 26: 326-333.
'Commensal gut bacteria: mechanisms of immune modulation ' () 26 Trends in Immunology : 326 -333.
Knorr, D., 1998. Technology aspects related to microorganisms in functional foods. Trends in Food Science and Technology 9: 295-306.
'Technology aspects related to microorganisms in functional foods ' () 9 Trends in Food Science and Technology : 295 -306.
Maassen, C.B., Van Holten-Neelen, C., Balk, F., Den Bak-Glashouwer, M.J., Leer, R.J., Laman, J.D., Boersma, W.J. and Claassen, E., 2000. Strain-dependent induction of cytokine profiles in the gut by orally administered Lactobacillus strains. Vaccine 18: 2613-2623.
'Strain-dependent induction of cytokine profiles in the gut by orally administered Lactobacillus strains ' () 18 Vaccine : 2613 -2623.
Marin, M.L., Lee, J.H., Murtha, J., Ustunol, Z. and Pestka, J.J., 1997. Differential cytokine production in clonal macrophage and T-cell lines cultured with Bifidobacteria. Journal of Dairy Science 80: 2713-2720.
'Differential cytokine production in clonal macrophage and T-cell lines cultured with Bifidobacteria ' () 80 Journal of Dairy Science : 2713 -2720.
Metchnikoff, E., 1908. Optimistic studies. Putman's Sons, New York, NY, USA.
Optimistic studies , ().
Perdigón, G., De Moreno, L.A., Valdez, J. and Rachid, M., 2002. Role of yoghurt in the prevention of colon cancer. European Journal of Clinical Nutrition 56 Suppl. 3: 65-68.
'Role of yoghurt in the prevention of colon cancer ' () 56 European Journal of Clinical Nutrition : 65 -68.
Reid, G., Zalai, C. and Gardiner, G., 2001. Urogenital Lactobacilli probiotics, reliability and regulatory issues. Journal of Dairy Science 84 Suppl. E: 164-169.
'Urogenital Lactobacilli probiotics, reliability and regulatory issues ' () 84 Journal of Dairy Science : 164 -169.
Taverniti, V. and Guglielmetti, S., 2011. The immunomodulatory properties of probiotic microorganisms beyond their viability (ghost probiotics: proposal of paraprobiotic concept). Genes and Nutrition 6: 261-274.
'The immunomodulatory properties of probiotic microorganisms beyond their viability (ghost probiotics: proposal of paraprobiotic concept) ' () 6 Genes and Nutrition : 261 -274.
Troy, E.B. and Kasper, D.L., 2010. Beneficial effects of Bacteroides fragilis polysaccharides on the immune system. Frontiers in Bioscience 15: 25-34.
'Beneficial effects of Bacteroides fragilis polysaccharides on the immune system ' () 15 Frontiers in Bioscience : 25 -34.
Ulsemer, P., Toutounian, K., Schmidt, J., Karsten, U. and Goletz, S., 2011. Safety assessment of the commensal strain Bacteroides xylanisolvens DSM 23964. Regulatory Toxicology and Pharmacology, in press. DOI: http://dx.doi.org/doi:10.1016/j.yrtph.2011.10.014.
Ulsemer, P., Toutounian, K., Schmidt, J., Leuschner, J., Karsten, U. and Goletz, S., 2012. Preliminary safety evaluation of a new Bacteroides xylanisolvens strain. Applied and Environmental Microbiology 78: 528-535.
'Preliminary safety evaluation of a new Bacteroides xylanisolvens strain ' () 78 Applied and Environmental Microbiology : 528 -535.
Yanagibashi, T., Hosono, A., Oyama, A., Tsuda, M., Hachimura, S., Takahashi, Y., Itoh, K., Hirayama, K., Takahashi, K. and Kaminogawa, S., 2009. Bacteroides induce higher IgA production than Lactobacillus by increasing activation-induced cytidine deaminase expression in B cells in murine Peyer's patches. Bioscience, Biotechnology and Biochemistry 73: 372-377.
'Bacteroides induce higher IgA production than Lactobacillus by increasing activation-induced cytidine deaminase expression in B cells in murine Peyer's patches ' () 73 Bioscience, Biotechnology and Biochemistry : 372 -377.
| Insgesamt | Letzte 365 Tage | In den letzten 30 Tagen | |
|---|---|---|---|
| Aufrufe von Kurzbeschreibungen | 22 | 0 | 0 |
| Gesamttextansichten | 678 | 200 | 21 |
| PDF-Downloads | 375 | 137 | 0 |
We recently presented the strain Bacteroides xylanisolvens DSM 23964 to be safe for use in food. In order to confirm the tolerance of healthy humans to a regular oral intake of the strain B. xylanisolvens DSM 23964, we here report on the safety data of two successive human studies: a randomised and double-blind parallel group-controlled pilot study with 41 volunteers receiving a daily dose of a pasteurised fermented milk product containing up to 8.5×1011B. xylanisolvens DSM 23964 cells for 3 weeks, and a randomised and placebo-controlled double-blind major study with 140 volunteers receiving the same product but spray-dried and containing up to 1012 cells for 6 weeks. In both studies no persistent side effects of any kind were reported. The measured haematological parameters, and the serum concentrations of immunoglobulin and of inflammatory markers (IL-6, CRP, IFN-γ) were unaffected by the supplementation in both studies. A small decrease in the phagocytic activity of granulocytes and a small increase of TNF-α detected in the pilot study were both invalidated by the major study. This study further revealed that the supplementation induced no modification in natural killer cell activity and in liver enzyme values (gamma-glutamyl-transferase, glutamate-oxalacetate transaminase, glutamate-pyruvate transaminase). Our results definitively demonstrate that the pasteurised B. xylanisolvens DSM 23964 strain is safe and well tolerated by healthy human individuals.
| Insgesamt | Letzte 365 Tage | In den letzten 30 Tagen | |
|---|---|---|---|
| Aufrufe von Kurzbeschreibungen | 22 | 0 | 0 |
| Gesamttextansichten | 678 | 200 | 21 |
| PDF-Downloads | 375 | 137 | 0 |